A carregar...
Publicação
Bausch + lomb company valuation - financial forecasts and competitor analysis
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.32 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
This work project conducts a company valuation of Bausch + Lomb and evaluates
different exit options for the company. The first part consists of the company’s financial
statement analysis and future projections. The second part consists of a valuation based on a
multiple regression approach. The third part contains the valuation of operational synergies in
case of a strategic acquisition scenario. The group part consists of Bausch + Lomb’s valuation
based on a discounted cash flow model (DCF) and relative valuation approaches. Considering
the DCF model, B + L’s enterprise value is estimated at $7,325 mn as of 31/12/2021.
Descrição
Palavras-chave
Bausch + lomb Company valuation Acquisition Pharmaceuticals Eye care